News

NuVax, a clinical stage pharmaceutical company, aims to develop novel immune-gene therapeutics that have the potential to impact and extend the quality of life for cancer patients. Through

As per the terms of the development and commercialisation agreement between the companies, in exchange for exclusive world-wide rights to commercialise specific products based on Mesoblast’s proprietary adult

GLYX-13 is Naurex’s lead glycine-site functional partial agonist (GFPA) selective modulator of the NMDA receptor. The novel GFPA class of compounds has been specifically designed to achieve the

Under the terms of the expanded agreement, Dicerna will receive a cash payment for exercise by Kyowa Hakko Kirin of an option to bring an additional target into

Ancora Pharma said that each eligible project was awarded approximately $244,000 through the program. The National Institutes of Health grants were awarded to projects with potential to result

Abacavir Sulfate tablets are used in combination with other medications to control HIV infection and is included in the ARV class of drugs known as nucleoside reverse transcriptase

OXIS claims that ErgoFlex is the only joint health complex containing the powerful antioxidant Ergothioneine (ERGO), and is specifically formulated to help the body fight the pain of

Zogenix and Desitin Pharma claim Sumavel DosePro offers fast acting, easy-to-use, needle-free subcutaneous administration of sumatriptan. Sumavel DosePro may offer a treatment alternative to oral and nasal triptans,

The integration helps to enable complete real-time patient electronic medical records (EMRs) at the Canadian Healthcare facility. Streamline Health’s integrated solution is designed to deliver improved efficiencies by